Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Yulinzhu for Women With Diminished Ovarian Reserve
NCT07550998Phase 3Recruiting
- Sponsor
- The University of Hong Kong
- Start
- Apr 2026
- Primary completion
- Oct 2027
- Modality
- TCM (Traditional Chinese Medicine)
- Countries
- 1
01
Overview
A Phase 3 trial of Yulinzhu in Diminished Ovarian Reserve (DOR), sponsored by The University of Hong Kong. Started Apr 2026; status: recruiting.
02
Drugs
Yulinzhu
03
Conditions
Diminished Ovarian Reserve (DOR)
Beyond the preview
Go deeper on NCT07550998.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07550998.